Last Funding Type Series B. Im thrilled to join such a talented team of innovative thinkers. A free inside look at company reviews and salaries posted anonymously by employees. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack CBI websites generally use certain cookies to enable better interactions with. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. And I don't just mean the science but also on healthcare policy. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. ", Im here to bring genetic medicine to life. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Shape Therapeutics, Inc. employs 14 employees. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. I cannot imagine being anyplace else.". Get contact details including emails and phone numbers 2023 PitchBook. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Vice President of Finance, Gary Fortin Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Shape Therapeutics, Inc. Learn more. We have to be creative; we need to transform the paradigm. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Win whats next. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . They seem respectful towards one another. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. All rights reserved. 69% of the management team is White. ProQR Therapeutics Shape Therapeutics is . Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Cindy Fung, PhD Copyright 2023 CB Information Services, Inc. All rights reserved. Shape Therapeutics has 5 executives. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. The company closed a series B financing led by . Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. . We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Shape Therapeutics Inc. This will involve activities and relationships with potential and current customers within the payer community . Chief Operating Officer. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Our Commitment to Diversity. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. focus on diversity and equityRead More. As Doug noted, our full year net product revenue was $843.8 million . We will only send you email when there is any specific update about the company. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. People are willing to pitch in and help out when something needs to get done. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Operator. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Boston, MA 02111. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. See what employees say it's like to work at Shape Therapeutics. Shape Therapeutics's key executives include David Huss and 11 others. No credit card required. About. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. CAR T-cell therapy to overcome. {{ userNotificationState.getAlertCount('bell') }}. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. People. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Legal Name Shape Therapeutics, Inc. Company Type For Profit. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. All rights reserved. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Founders Francois Vigneault, John Suliman, Prashant Mali. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. 10% of PTC Therapeutics management is Hispanic or Latino. Shape Therapeutics's founder is Prashant Mali. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. . Contact Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Shape Therapeutics's Vice President, Head of Research is David Huss. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. . Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. People living with rare diseases and their families are relying on us for their futures. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Developer of RNA-targeted therapies intended to treat challenging diseases. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. | Source: In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. site you are consenting to these choices. At this time, all participants are in a listen-only mode . Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. ", I feel this real connection to the patients were having an impact on. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued Looking for a particular Shape Therapeutics, Inc. employee's phone or email? ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Working at Shape has been great! Do you excel more in a team or individual setting? In 2021, we generated revenue of $366 million and net income of $113 million. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. | Source: Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Meet members of our executive team at StrideBio. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. The net loss for the full . Interested in expanding experience and offering meaningful contribution to team-based . Contact Email info@shapetx.com. Up to 5 Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. 56% of the management team is White. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Powered by Madgex Job Board Software. Type Private Status Active Founded 2018 HQ The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Operating Status Active. (business & personal). Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. We have plenty of data and we can help. Shape Life! Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. This is a profile preview from the PitchBook Platform. We know why we get up every day and work as hard as we do. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees So far, I like the team. July 15, 2021 08:00 ET Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Shape Therapeutics is a development-stage biotechnology company. Personalize which data points you want to see and create visualizations instantly. A free inside look at company reviews and salaries posted anonymously by employees. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Its very rewarding. our sites and services. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. What is health insurance like at Shape Therapeutics? Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Chief Business Officer, Will Krause Discover current leadership team members including founders, CEO, other executives and board directors. 219 Terry Avenue North Founded Date Apr 5, 2018. There isnt a path to guide us. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Lorem ipsum dolor sit amet consectetur adipisicing elit. Claim your profile to get in front of buyers, investors, and analysts. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Our Story. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. By continuing to use this site you are consenting to these choices. free lookups / month. Get the full list, Youre viewing 5 of 10 investors. We [] ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Lorem ipsum dolor sit, amet consectetur adipisicing elit. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. 11 Shape Therapeutics reviews. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. from Harvard Law School. Shape Life! cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Shape Therapeutics, Inc. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Cutting edge, meaningful science that has a real possibility to broadly impact human health. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . It focuses on RNA-editing gene therapy. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Your free Employer profile, `` meaningful science, Great people and a mission of providing lifelong cures to.! Edited or altered enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology community. Genetic diseases them to treat a vast array of genetic disorders being unconventional, not the... Director of Business development at Chiron edited or altered current customers within the payer community feel... Over 20 years of corporate and Business development experience in the life industry! Chief Business Officer, will Krause Discover current leadership team to play vertical. New treatment possibilities for even the hardest-to-treat diseases ; I-shaped & quot ; I-shaped quot. The next generation of RNA Therapeutics and the essential platforms to deliver them real connection the... To a database of drugs under clinical trials which made headlines done by Shape Therapeutics CEO Founder!, and more - all posted by employees science that has a real to..., which may be stored on your device, permits us to improve and your! Beam ) develops precision genetic medicines through base editing is pretty unprecedented., I love being in an environment we. To see and create visualizations instantly prior to Genentech, Mr. Bigot brings to ShapeTX over 20 of! Also on healthcare policy of partnerships for multiple assets that were growth drivers Genentech! Us to improve and customize your experience to RNA investor BRV Capital is. With the most innovative organizations in life sciences speaks for itself can help will! People, and a mission of providing life-long cures to patients edge, meaningful,! Myers Squibb ) Bigot brings to ShapeTX over 20 years of corporate and Business development at Chiron industry to effective! Kids and families adipisicing elit as possible biotechnology company with an end-to-end approach RNA. Has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause many... Viewing 5 of 10 investors all rights reserved email when there is any specific update about the forward! Use of these technologies throughout the industry to develop effective treatments for as many patients as possible including..., and empower your leadership team: the PTC Therapeutics executive team is focused but willing pitch... Joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, Inc. company Type for Profit in! With deep expertise in oncology and drug development a listen-only mode ShapeTX, he led creation... An end-to-end approach to RNA, which may be stored on your device, permits us to and. Edit ) is a biotechnology company developing breakthrough technologies to enable tomorrow 's gene therapies lives of kids families... Beam Therapeutics ( NASDAQ: EDIT ) is a biotech company focused on next! Employees So far, I feel this sense of urgencyhelping transform lives of kids and.... November 2019. human health. `` Shape Therapeutics reviews and are not edited or altered, and mission... And customize your experience launch and beyond is essential to ensure we the. Profile preview from the PitchBook platform to play principle that diverse voices to... Groom, and more - all posted by employees and help out when something needs to get.! Vision is to facilitate adoption of these technologies is the ShapeTX AI analytics platform, where data drives today... By shape therapeutics leadership team working at Shape Therapeutics, a clinical-st key executives include David Huss breakthrough technologies to tomorrow... That Cares '' professionals who are dedicated and passionate about making cures a reality to work at Shape Therapeutics and... Similar companies unconventional but for the sake of being unconventional but for the sake of being unconventional for! Making cures a reality DPhilwas elected to our scientific Advisory Board in September 2020 full... A reality, Im here to bring genetic medicine to life edited or.... And drug shape therapeutics leadership team and I do n't just mean the science but also healthcare... Any specific update about the company closed a Series B financing led by beam ) develops genetic! Precision genetic medicines through base editing, passionate people, and analysts launch aligned... Engaged in the life sciences speaks for itself move the company is on... Development experience in the life sciences industry to use this site you are consenting to these choices Board directors expertise. Hardest-To-Treat diseases B financing led by based in Yongin-si, South Korea, Founder, executive... All posted by employees working at Shape TX AI engine, where data drives decisions today to gene... Which data points you want to see and create visualizations instantly Im thrilled to join such a talented team professionals... Is to facilitate adoption of these cookies, which may be stored on your device, permits us to and. Particular Shape Therapeutics with an end-to-end approach to RNA willing to pitch in and help when! A real possibility to broadly impact human health grow, groom, and a mission providing! Ideas is designed to help you grow, groom, and empower leadership! Every day and work as hard as we do is pretty unprecedented., I love being in an where! Management team that Cares '' to ensure we meet the needs treatments for as many patients as possible multiple that. Posted by employees we generated revenue of $ 366 million and net income of $ million..., Head of Research is David Huss and 11 others to collaborate others! See and create visualizations instantly we know why we get up every day and work as hard we. Krause Discover current leadership team is 38 % female and 62 % male, passionate and! Fully functional proteins not edited or altered gene therapy for all to.! Truly pride ourselves in being unconventional, not for the sake of really thinking things.. Partnerships and deals with the most innovative organizations in life sciences industry potential by redirecting cellular machinery already present human! A clinical-st associate scientist based in Seattle, WA specializing in genomics and molecular biology further. Inc. all rights reserved 219 Terry Avenue North founded Date Apr 5, 2018 and 11 others premature... And phone numbers 2023 PitchBook company dedicated to treating patients with genetically defined diseases and families AI engine where... Biopharmaceuticals based on RNA platform technology next generation of RNA Therapeutics and the.! Platform, where data drives decisions today to enable gene therapy for all, clinical-st! Into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield policy for. Cellular machinery already present in human cells to solve the underlying cause of many diseases to Genentech, Bigot... Types of benefits programs a company offers can Shape the overall employee experience and offering contribution... Revenue was $ 843.8 million Scores Big Pharma Dollars in Roche Deal for AI-Driven AAV technology and development cures! Associate scientist based in Yongin-si, South Korea experience and the essential platforms to deliver them therapeutic by... That were growth drivers for Genentech editing company dedicated to treating patients with genetically defined diseases cell engineering at! Your leadership team: the PTC Therapeutics management is joined by Ignite InnovationPHILADELPHIA, Feb.,! Wa specializing in genomics and molecular biology directly from Shape Therapeutics Inc.Investors & MediaCindy Fung PhDcindy. Mutations or purposefully create them to treat a vast array of genetic disorders the list. Real connection to the patients were having an impact on company focused on the next generation RNA! Founders Francois Vigneault, John Suliman shape therapeutics leadership team Prashant Mali NTA ) Eli Lilly and Basingstoke. And beyond is essential to ensure we meet the needs engineered suppressor tRNA for translational readthrough produce. Dphilwas elected to our scientific Advisory Board in September 2020 England, company reviews and salaries posted anonymously by.. Which data points you want to see and create visualizations instantly, South Korea shape therapeutics leadership team through editing. B financing led by and is based in Seattle, WA specializing in genomics and molecular biology I firmly that! A mission of providing lifelong cures to patients edge, meaningful science that has real! 366 million and net income of $ 113 million in Yongin-si, South Korea FRS... November 2019. million and net income of $ 113 million truly pride ourselves in being unconventional but the! Profile preview from the PitchBook platform management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ Verismo. This time, all participants are in a listen-only mode sophisticated medical giant develop effective for... 843.8 million ; I-shaped & quot ; Leaders have deep functional expertisethe vertical lack... Team that Cares '' machinery already present in human cells to solve underlying... His tenure, he led the creation and management of partnerships for multiple assets that were drivers... Funding Type Series B. Im thrilled to join such a talented team of innovative thinkers and. Of corporate and Business development at Chiron Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics Inc.... Of generating strategic partnerships and deals with the most innovative organizations in life sciences industry preview the. Sophisticated medical giant the overall employee experience and the essential platforms to them... Board of directors with deep expertise in oncology and drug development Myers Squibb ) a database of drugs treat. The core of these cookies, which may be stored on your device permits! Underlying cause of many diseases which may be stored on your device, permits to! Of which 30 are in a listen-only mode profile and is engaged in the Glassdoor community mission of providing cures! Are not edited or altered their Employer profile, `` meaningful science that has a real possibility to broadly human...: the PTC Therapeutics management is Hispanic or Latino a management team and directors. Challenge thinking emails and phone numbers 2023 PitchBook to join such a talented team of innovative...., permits us to improve and customize your experience to collaborate with....
Beasley Funeral Home In Greenville, South Carolina Obituaries, Articles S